STOCK TITAN

SVP & Chief HR Officer at BCPC (BCPC) granted stock and options

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BCPC senior vice president and Chief HR Officer Michael Brent Tignor reported multiple equity compensation transactions. On February 11, 2026, he acquired 1,200 shares of restricted common stock at $0, vesting over three years, and 1,929 shares from vested performance stock units for the 2023–2025 period, including 31 dividend equivalent shares.

To cover tax obligations on these vestings, 991 shares were withheld at $178.68 on February 11, 2026 and 165 shares were withheld at $177.49 on February 12, 2026. He also received a stock option for 4,400 shares at an exercise price of $178.68, vesting 20% in year one, 40% in year two, and 40% in year three, expiring on February 11, 2036. Following these transactions he directly held 10,723 common shares, plus 1,456 shares indirectly through a 401(k) plan and 4,400 stock options.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tignor Michael Brent

(Last) (First) (Middle)
C/O BALCHEM CORPORATION
5 PARAGON DRIVE

(Street)
MONTVALE NJ 07645

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Chief HR Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/11/2026 A 1,200(1) A $0 9,950 D
Common Stock 02/11/2026 A 1,929(2) A $0 11,879 D
Common Stock 02/11/2026 F 991(3) D $178.68 10,888 D
Common Stock 02/12/2026 F 165(4) D $177.49 10,723 D
Common Stock 1,456 I 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $178.68 02/11/2026 A 4,400 (5) 02/11/2036 Common Stock 4,400 $0 4,400 D
Explanation of Responses:
1. Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
2. Represents the vesting of performance stock units (includes 31 dividend equivalent shares) for the 2023-2025 performance period.
3. 991 of the 1,929 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
4. Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
5. Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
/s/ Travis Larsen, Attorney in Fact for Michael Brent Tignor 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did BCPC officer Michael Brent Tignor report?

He reported equity compensation transactions, including grants of restricted stock, vested performance stock units, related tax-withholding share dispositions, and a new stock option grant. These transactions adjusted his direct, indirect, and derivative holdings in the issuer’s common stock.

How many BCPC common shares did Michael Brent Tignor acquire on February 11, 2026?

He acquired 1,200 restricted common shares and 1,929 shares from vested performance stock units on February 11, 2026. The performance award covered the 2023–2025 period and included 31 dividend equivalent shares credited at vesting.

Why were some BCPC shares disposed of in Michael Brent Tignor’s Form 4?

Shares were withheld solely to cover tax obligations on vesting equity awards. Specifically, 991 vested performance stock unit shares and 165 restricted shares were withheld at stated market prices, classified as tax-withholding dispositions rather than open-market sales.

What stock option grant did Michael Brent Tignor receive from BCPC?

He received a stock option covering 4,400 shares of common stock at a $178.68 exercise price, expiring February 11, 2036. The option vests 20% in year one, 40% in year two, and 40% in year three, subject to continued service.

What are Michael Brent Tignor’s BCPC share and option holdings after these transactions?

After the reported transactions, he directly held 10,723 common shares and indirectly held 1,456 shares through a 401(k) plan. He also beneficially owned 4,400 stock options, reflecting the new grant reported in the derivative securities table.
Balchem Corp

NASDAQ:BCPC

View BCPC Stock Overview

BCPC Rankings

BCPC Latest News

BCPC Latest SEC Filings

BCPC Stock Data

5.41B
31.82M
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE